Conservative Treatment With Blood Flow Restriction in Patients With Total ACL Rupture. "Randomized Clinical Trial"

Launched by EUROPEAN UNIVERSITY CYPRUS · Dec 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called blood flow restriction (BFR) exercise in patients who have completely torn their anterior cruciate ligament (ACL). The main goal is to find out if adding BFR to standard treatment, which includes wearing a knee brace and doing exercises, helps people recover better. Researchers are comparing two groups: one group will use BFR during exercises, while the other will do the same exercises but without the BFR.

To be eligible for the trial, participants need to have a confirmed complete ACL tear shown by an MRI and should be able to communicate and understand instructions in Greek. They must be willing to keep their leg still as per the study guidelines. During the trial, participants will wear a knee brace for six weeks and follow a specific exercise program at home. It's important to note that certain health conditions, like heart disease or pregnancy, may prevent someone from participating. This trial aims to provide valuable information that could improve treatment approaches for ACL injuries in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • MRI-confirmed complete rupture of ACL. Ability to communicate and read fluently in Greek and be willing to keep their leg immobilised for the required period based on the study protocol.
• Exclusion Criteria:
• • Heart disease, overweight, diabetes, pregnancy, thrombophilia, atrial fibrillation, heart failure, cancer, use of drugs that may increase blood clotting, use of hormones or contraceptives, any reason for not using BFR e.g., an open wound or serious skin problems and/or allergies to the cuff material.